Cognitive-behavioral therapy for adults with avoidant/restrictive food intake disorder

IF 1.7 Q3 PSYCHIATRY
Jennifer J. Thomas , Kendra R. Becker , Lauren Breithaupt , Helen Burton Murray , Jenny H. Jo , Megan C. Kuhnle , Melissa J. Dreier , Stephanie Harshman , Danielle L. Kahn , Kristine Hauser , Meghan Slattery , Madhusmita Misra , Elizabeth A. Lawson , Kamryn T. Eddy
{"title":"Cognitive-behavioral therapy for adults with avoidant/restrictive food intake disorder","authors":"Jennifer J. Thomas ,&nbsp;Kendra R. Becker ,&nbsp;Lauren Breithaupt ,&nbsp;Helen Burton Murray ,&nbsp;Jenny H. Jo ,&nbsp;Megan C. Kuhnle ,&nbsp;Melissa J. Dreier ,&nbsp;Stephanie Harshman ,&nbsp;Danielle L. Kahn ,&nbsp;Kristine Hauser ,&nbsp;Meghan Slattery ,&nbsp;Madhusmita Misra ,&nbsp;Elizabeth A. Lawson ,&nbsp;Kamryn T. Eddy","doi":"10.1016/j.jbct.2020.10.004","DOIUrl":null,"url":null,"abstract":"<div><p>There are currently no evidence-based treatments for adults with avoidant/restrictive food intake disorder (ARFID). The purpose of this study was to evaluate the acceptability, feasibility, and proof-of-concept of cognitive-behavioral therapy for ARFID (CBT-AR) for adults. Males and females (ages 18–55 years) were offered 20-30 outpatient sessions of CBT-AR delivered by one of five therapists. Of 18 eligible adults offered CBT-AR, 15 chose to participate and 14 completed treatment. All patients endorsed high ratings of treatment credibility and expected improvement after the first session, and 93% of completers provided high ratings of satisfaction at the conclusion of treatment. Therapists rated the majority (80%) of patients as “much improved” or “very much improved.” Based on intent-to-treat analyses, ARFID severity on the Pica, ARFID, and Rumination Disorder Interview (PARDI) showed a large and significant decrease from pre- to post-treatment; and patients incorporated a mean of 18.0 novel foods. The underweight subgroup (<em>n</em> <!-->=<!--> <!-->4) gained an average of 11.38 pounds, showing a large and significant increase in mean BMI from the underweight to the normal-weight range. At post-treatment, 47% of patients no longer met criteria for ARFID. To our knowledge, this is the first prospective treatment study of ARFID in adults. The findings of this study provide preliminary evidence of feasibility, acceptability, and proof-of-concept of CBT-AR for heterogeneous presentations of ARFID in adults. Randomized controlled trials are needed to confirm these findings. ClinicalTrials.gov Identifier: <span>NCT02963220</span><svg><path></path></svg>.</p></div>","PeriodicalId":36022,"journal":{"name":"Journal of Behavioral and Cognitive Therapy","volume":"31 1","pages":"Pages 47-55"},"PeriodicalIF":1.7000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jbct.2020.10.004","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Behavioral and Cognitive Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589979120300470","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 17

Abstract

There are currently no evidence-based treatments for adults with avoidant/restrictive food intake disorder (ARFID). The purpose of this study was to evaluate the acceptability, feasibility, and proof-of-concept of cognitive-behavioral therapy for ARFID (CBT-AR) for adults. Males and females (ages 18–55 years) were offered 20-30 outpatient sessions of CBT-AR delivered by one of five therapists. Of 18 eligible adults offered CBT-AR, 15 chose to participate and 14 completed treatment. All patients endorsed high ratings of treatment credibility and expected improvement after the first session, and 93% of completers provided high ratings of satisfaction at the conclusion of treatment. Therapists rated the majority (80%) of patients as “much improved” or “very much improved.” Based on intent-to-treat analyses, ARFID severity on the Pica, ARFID, and Rumination Disorder Interview (PARDI) showed a large and significant decrease from pre- to post-treatment; and patients incorporated a mean of 18.0 novel foods. The underweight subgroup (n = 4) gained an average of 11.38 pounds, showing a large and significant increase in mean BMI from the underweight to the normal-weight range. At post-treatment, 47% of patients no longer met criteria for ARFID. To our knowledge, this is the first prospective treatment study of ARFID in adults. The findings of this study provide preliminary evidence of feasibility, acceptability, and proof-of-concept of CBT-AR for heterogeneous presentations of ARFID in adults. Randomized controlled trials are needed to confirm these findings. ClinicalTrials.gov Identifier: NCT02963220.

Abstract Image

成人回避/限制性食物摄入障碍的认知行为治疗
目前还没有针对成人回避/限制性食物摄入障碍(ARFID)的循证治疗方法。本研究的目的是评估成人ARFID认知行为治疗(CBT-AR)的可接受性、可行性和概念验证。男性和女性(年龄18-55岁)由5名治疗师中的1名提供20-30次CBT-AR门诊治疗。在接受CBT-AR治疗的18名符合条件的成年人中,15人选择参加,14人完成治疗。所有患者在第一次治疗后都对治疗可信度和预期改善有很高的评价,93%的完成者在治疗结束时提供了很高的满意度。治疗师对大多数(80%)患者的评价是“大有改善”或“大有改善”。根据意向治疗分析,异食癖、ARFID和反刍障碍访谈(PARDI)的ARFID严重程度从治疗前到治疗后显著降低;患者平均摄入18.0种新食物。体重不足亚组(n = 4)平均增加11.38磅,显示出从体重不足到正常体重范围的平均BMI大幅显著增加。在治疗后,47%的患者不再符合ARFID的标准。据我们所知,这是ARFID在成人中的首次前瞻性治疗研究。本研究的结果为CBT-AR治疗成人ARFID异质表现的可行性、可接受性和概念验证提供了初步证据。需要随机对照试验来证实这些发现。ClinicalTrials.gov标识符:NCT02963220。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Behavioral and Cognitive Therapy
Journal of Behavioral and Cognitive Therapy Psychology-Clinical Psychology
CiteScore
3.30
自引率
0.00%
发文量
38
审稿时长
60 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信